Medrol and Failure to thrive - a phase IV clinical study of FDA data

Summary:

Failure to thrive is reported as a side effect among people who take Medrol (methylprednisolone), especially for people who are male, 60+ old, also take Ondansetron, and have Pemphigus.

The phase IV clinical study analyzes which people have Failure to thrive when taking Medrol. It is created by eHealthMe based on reports of 23,951 people who have side effects when taking Medrol from the FDA, and is updated regularly.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.

What is Failure to thrive?

Failure to thrive (inadequate weight gain and physical growth in children) is found to be associated with 764 drugs and 1,168 conditions by eHealthMe. Check the latest studies of Failure to thrive.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

23,951 people reported to have side effects when taking Medrol.
Among them, 12 people (0.05%) have Failure to thrive.

Among these 12 people:

What is the gender of people who have Failure to thrive when taking Medrol? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Failure to thrive when taking Medrol? *

What are other drugs people take besides Medrol? *

What are other side effects people have besides Failure to thrive? *

Iron Deficiency Anaemia: 5 people, 41.67%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 25.00%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 3 people, 25.00%
Arrhythmias (irregular heartbeat): 3 people, 25.00%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 3 people, 25.00%
Body Height Decreased: 3 people, 25.00%
Bone Pain: 3 people, 25.00%
Cellulitis (infection under the skin): 3 people, 25.00%
Dental Caries: 3 people, 25.00%
Drug Administration Error: 3 people, 25.00%

What are the existing conditions these people have? *

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 3 people, 25.00%
Pain: 2 people, 16.67%
Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
Neck Pain: 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 16.67%
Broken Bone: 2 people, 16.67%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 8.33%
Cardiac Disorder: 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Medrol and have Failure to thrive?

- Check whether Failure to thrive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Medrol:

Medrol (24,443 reports)

Browse all side effects of Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Failure to thrive:

Failure to thrive (764 drugs)

Browse all the conditions that are associated with Failure to thrive:

Failure to thrive (1,168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Medrol) and Medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.